Reducing unnecessary high-dose heartburn medication in adults
Part of Digestive system clinical trials.
This study tests whether it is safe and helpful to reduce or stop daily high-dose heartburn medications (called PPIs) in patients who might not need them anymore. It is for adults who take a strong PPI every day and can communicate in German.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You take a proton pump inhibitor (PPI) daily for 8 weeks or more
- You take a high dose of a PPI (for example, at least 40 mg of pantoprazole or omeprazole daily)
- You understand and speak German well enough to follow the study
- You do not have a clear medical reason for long-term PPI use (like a bleeding ulcer or severe acid reflux), and you are not at high risk for stomach bleeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether educating doctors can reduce unnecessary prescriptions of proton pump inhibitors (PPIs, a type of acid-reducing medicine). If you are an adult patient who has been prescribed a PPI that might not be needed, your doctor may join this study to improve your care.
This trial tests whether giving doctors regular feedback can help reduce prescriptions of certain medicines (sleeping pills, acid reducers, and painkillers) that may be risky for older people. If you are 65 or older and take one of these medicines long-term, the study aims to improve your care by helping your doctor review if the medicine is still needed.
This study tests whether it is safe to stop taking acid-reducing pills (PPIs) for people with inactive IBD. If you have been on a PPI for over 6 months and your IBD is stable, you may be able to join.
This study looks at how acid-reducing medicines called proton pump inhibitors (like omeprazole) affect the natural bacteria in your gut. You'll be asked to take a small capsule that collects samples from your digestive system to see how these medicines change your gut health.
This study checks whether a special test of the esophagus after meals can find the exact reason for ongoing reflux symptoms when proton pump pills (PPIs) don’t help. It may help doctors choose the right next treatment for people whose reflux symptoms keep coming back.
This study tests whether stopping proton-pump inhibitor (PPI) acid-reducing medication is safe and works as expected for people with liver cirrhosis. Participants switch to either the study medication or a placebo (inactive pill) under close monitoring.
Hear when a new Inappropriate Prescribing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.